Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Study: CAR T cell therapy is a safe, effective therapy for high-risk large B-cell lymphoma

Study: CAR T cell therapy is a safe, effective therapy for high-risk large B-cell lymphoma

Mice infused with CD5-deleted CAR T cells showed significant reduction in tumor size

Mice infused with CD5-deleted CAR T cells showed significant reduction in tumor size

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

Protein interactions could serve as therapeutic targets to treat viral infections

Protein interactions could serve as therapeutic targets to treat viral infections

Cell survival protein could protect the kidneys from 'bystander' damage during cancer therapy

Cell survival protein could protect the kidneys from 'bystander' damage during cancer therapy

Scientists identify mechanism involved in new precision cancer drug for blood cancers

Scientists identify mechanism involved in new precision cancer drug for blood cancers

Cell nucleus may enable the cells to evade crowded environments

Cell nucleus may enable the cells to evade crowded environments

Researchers discover how specific molecules promote cancer progression

Researchers discover how specific molecules promote cancer progression

Immunotherapy using CAR NKT cells shows promise for treating solid tumors

Immunotherapy using CAR NKT cells shows promise for treating solid tumors

VAV1 gene mutations may promote growth of T-cell tumors in laboratory mice

VAV1 gene mutations may promote growth of T-cell tumors in laboratory mice

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

CAR T cell therapy can predict treatment outcomes in patients with large B-cell lymphoma

CAR T cell therapy can predict treatment outcomes in patients with large B-cell lymphoma

Memory training for the immune system

Memory training for the immune system

Eliminating tumors with engineered ‘off-the-shelf’ therapeutic T cells

Eliminating tumors with engineered ‘off-the-shelf’ therapeutic T cells

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

New approach is more effective in treating certain blood cancers

New approach is more effective in treating certain blood cancers

Reactivating divergent signaling pathways to enhance cancer treatment

Reactivating divergent signaling pathways to enhance cancer treatment

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

New technology generates immune response by delivering antigens to APCs in the spleen

New technology generates immune response by delivering antigens to APCs in the spleen